Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel M Williams

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Hormone Research in Paediatrics|June 23, 2025
Little Loopers: A Case Series of Automated Insulin Delivery Usage with Standard and Diluted Insulin in Very Young Children with Diabetes MellitusBenjamin G Fisher, Julia Ware, Paul Geetha Paul Nicholsion, et al.
Diabetes|July 29, 2006
Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetesTero Saukkonen, Fariba Shojaee-Moradie, Rachel M Williams, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistanceFiona M Regan, Rachel M Williams, Anna McDonald, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetesTero Saukkonen, Rakesh Amin, Rachel M Williams, et al.
Pediatric Diabetes|November 25, 2021
Safe and effective use of a hybrid closed-loop system from diagnosis in children under 18 months with type 1 diabetesXanthippi Tseretopoulou, Vidya Viswanath, Sara Hartnell, et al.
Neuro-Oncology Advances|July 10, 2020
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumorsMatthew J Murray, Thankamma Ajithkumar, Fiona Harris, et al.
Hormone Research in Paediatrics|July 11, 2022
Early Postnatal Use of Glibenclamide in Permanent Neonatal Diabetes Secondary to Antenatally Diagnosed KJCN11 MutationSandra Walton-Betancourth, Jennifer Ashford, Kathy Beardsall, et al.
Clinical Science (London, England : 1979)|December 20, 2008
Intramyocellular lipid levels are associated with peripheral, but not hepatic, insulin sensitivity in normal healthy subjectsBurak Salgin, Alison J Sleigh, Rachel M Williams, et al.
Science (New York, N.Y.)|May 29, 2004
A family with severe insulin resistance and diabetes due to a mutation in AKT2Stella George, Justin J Rochford, Christian Wolfrum, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Hormone Research in Paediatrics|June 23, 2025
Little Loopers: A Case Series of Automated Insulin Delivery Usage with Standard and Diluted Insulin in Very Young Children with Diabetes MellitusBenjamin G Fisher, Julia Ware, Paul Geetha Paul Nicholsion, et al.
Diabetes|July 29, 2006
Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetesTero Saukkonen, Fariba Shojaee-Moradie, Rachel M Williams, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistanceFiona M Regan, Rachel M Williams, Anna McDonald, et al.
The Journal of Clinical Endocrinology and Metabolism|September 10, 2004
Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetesTero Saukkonen, Rakesh Amin, Rachel M Williams, et al.
Pediatric Diabetes|November 25, 2021
Safe and effective use of a hybrid closed-loop system from diagnosis in children under 18 months with type 1 diabetesXanthippi Tseretopoulou, Vidya Viswanath, Sara Hartnell, et al.
Neuro-Oncology Advances|July 10, 2020
Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumorsMatthew J Murray, Thankamma Ajithkumar, Fiona Harris, et al.
Hormone Research in Paediatrics|July 11, 2022
Early Postnatal Use of Glibenclamide in Permanent Neonatal Diabetes Secondary to Antenatally Diagnosed KJCN11 MutationSandra Walton-Betancourth, Jennifer Ashford, Kathy Beardsall, et al.
Clinical Science (London, England : 1979)|December 20, 2008
Intramyocellular lipid levels are associated with peripheral, but not hepatic, insulin sensitivity in normal healthy subjectsBurak Salgin, Alison J Sleigh, Rachel M Williams, et al.
Science (New York, N.Y.)|May 29, 2004
A family with severe insulin resistance and diabetes due to a mutation in AKT2Stella George, Justin J Rochford, Christian Wolfrum, et al.
Pageof 3